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Several epidemiological studies have shown an inverse association between the consumption of polyphenol-rich foods and risk of
cardiovascular diseases.However, accuracy and reliability of these studiesmay be increased using urinary total polyphenol excretion
(TPE) as a biomarker for total polyphenol intake. Our aim was to assess if antioxidant activity, measured by a Folin-Ciocalteu
assay in urine, is correlated with an improvement in cardiovascular risk factors (blood pressure and serum glucose, cholesterol,
HDL-cholesterol, LDL-cholesterol, and triglyceride concentrations) in an elderly population at high risk. A longitudinal study was
performedwith 573 participants (aged 67.3± 5.9) from the PREDIMED study (ISRCTN35739639).Weused Folin-Ciocalteumethod
to determine TPE in urine samples, assisting with solid phase extraction. Participants were categorized into three groups according
to changes in TPE. Multiple linear regression models were used to assess relationships between TPE and clinical cardiovascular
risk factors, adjusting for potential confounders. After a 5-year follow-up, significant inverse correlations were observed between
changes in TPE and plasma triglyceride concentration (𝛽 = −8.563; 𝑃 = 0.007), glucose concentration (𝛽 = −4.164; 𝑃 = 0.036),
and diastolic blood pressure (𝛽 = −1.316; 𝑃 = 0.013). Our results suggest that the consumption of more polyphenols, measured as
TPE in urine, could exert a protective effect against some cardiovascular risk factors.
1. Introduction
Cardiovascular diseases (CVDs) are considered to be the
leading global cause of death, accounting for 17.3 million
deaths per year, which is predicted to rise to more than
23.6 million by 2030 [1]. The main causes of CVDs involve
nonmodifiable risk factors, such as age, sex, and family
history of coronary heart disease (CHD), and modifiable risk
factors, such as an unhealthy diet, lack of physical activity,
smoking, and excessive alcohol intake [2, 3]. Therefore, an
improvement of dietary habits could help to prevent CVDs.
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Several studies have described protective roles of
polyphenols in the cardiovascular system.The cardiovascular
protection by polyphenol consumption can be explained by
various mechanisms, including their anti-inflammatory
properties, antioxidant capacity, improvement in
endothelial function, inhibition of platelet aggregation
and antithrombotic properties, and mechanisms that are
not mutually exclusive [4–8]. Hence, further exploration of
polyphenol consumption will help to discern its beneficial
effects on human health. Prior information on polyphenol
intake has often been collected through food frequency
questionnaires (FFQs) or dietary recalls, whose bias can
result in data not so accurate [9]. Therefore, in order to
analyse associations between polyphenol intake and main
cardiovascular risk factors, there is a need for biomarkers that
can accurately reflect polyphenol intakein human studies.
The Folin-Ciocalteu method, an antioxidant assay based
on electron transfer that measures the reductive capacity
of an antioxidant, has been widely applied for measur-
ing total polyphenol content in plant-derived food and
recently in biological samples for clinical studies [10, 11].
Briefly, polyphenols from urine samples react with the Folin-
Ciocalteu reagent to form a blue complex in alkalinemedium,
measured in spectrophotometry at 765 nm [12]. A solid phase
extraction method is used to clean up the sample from
possible interferences. This measurement of total urinary
polyphenol excretion (TPE) has been considered as reliable
biomarker of total polyphenol intake in recent years [8, 13, 14].
Several studies have addressed the relationship between
polyphenol intake and cardiovascular risk factors; however,
the results have led to mixed and inconsistent conclusions.
Two studies conducted in healthy participants observed that
improvement in cardiovascular health was due to higher
HDL levels after intake of polyphenol-rich foods [15, 16].
Different results were obtained in other two studies in
overweight subjects: one showed cardioprotective effects due
to a reduction in body weight and an improvement in
total cholesterol and LDL concentration after ingestion of a
polyphenol extract from Ecklonia cava, while the other study
observed a reduction in fasting glucose concentration when
supplied with polyphenol-rich dark chocolate [17, 18]. Addi-
tionally, reduction in systolic blood pressure was observed in
hemodialysis patients after the consumption of a polyphenol-
rich beverage for one year [19]. Moreover, in the frame
of the PREDIMED study, we found that specific categories
of polyphenols, calculated through yearly FFQs and the
Phenol-Explorer database, were significantly associated with
decreased CVD risk [20].
Most of the aforementioned studies were conducted
in small populations or over short periods of time. The
association between polyphenol intake and cardiovascular
risk factors has also been evaluated in large, long-term
epidemiological trials, but with the limitations associated
with using FFQs [21–24]. Therefore, the aim of the present
study was to apply the reliable and validated antioxidant
activity test, the Folin-Ciocalteu method, in urine samples
as a biomarker of total polyphenol intake, to analyse the
association between polyphenol intake and cardiovascular
risk factors in an elderly population at high cardiovascular
risk after a long-term follow-up (median: 4.8 years).
2. Methods
The present study was conducted within the frame of the
PREDIMED study, which aimed to assess effects of the
Mediterranean diet on the primary prevention of CVDs in
Spain. The protocol and recruitment methods have been
reported in detail elsewhere [25]. Eligible participants were
men aged 55–80 and women aged 60–80 years without any
history of cardiovascular disease but fulfilling at least one
of the following two criteria: type-2 diabetes or three or
more cardiovascular risk factors (family history of early-onset
CVDs, hypertension, current smoking, lowHDL-cholesterol,
high LDL-cholesterol, and overweight or obesity). Exclusion
criteria included any severe chronic illness, previous history
of CVDs, alcohol or drug abuse, body mass index (BMI) of
more than 40 kg/m2, and history of allergy or intolerance
to olive oil or nuts. The trial was stopped after a median
follow-up of 4.8 years due to the benefit of theMediterranean
diet with respect to major cardiovascular events: myocardial
infarction, stroke, or death from cardiovascular causes (anal-
ysis performed by the Drug and Safety Monitoring Board of
the trial), compared to a control low-fat diet [26].
The present longitudinal analysis included 612 volunteers,
randomly selected from two recruitment centers in Spain.
All participants provided written informed consent, and the
protocol was approved by the Institutional Review Boards of
the participating centers and registered.
2.1. Nutritional Assessments. Dietary habits of participants
were assessed through a validated 137-item FFQ [27]. Nutri-
ent intake was adjusted by calories using the residuals’
method. Information about lifestyle, health condition, edu-
cation, history of illnesses, and medication use was collected
by a 47-item general questionnaire. The degree of adher-
ence to the Mediterranean diet was assessed by a 14-point
questionnaire [28]. Physical activity was assessed using the
validated Spanish version of the Minnesota Leisure-Time
Physical Activity Questionnaire [29]. All questionnaires were
administered and repeated annually during the follow-up by
trained staff in face-to-face interviews.
Information on polyphenol intake was obtained using
the FFQ and the Phenol-Explorer database. The relationship
between food items in the FFQ and the database has been
described previously [30]. The content of total polyphenol
intake equals the sum of all the individual polyphenol from
each food item.
2.2. TPE Measurements. Urine samples were collected and
coded and then immediately shipped to a central laboratory,
to be stored at −80∘C until analysed. The Folin-Ciocalteu
method was applied to determine the content of TPE, using
a clean-up procedure with solid phase extraction (SPE)
performed in 96-well plate cartridges (Oasis MAX), which
helped to remove urinary interferences. Finally, TPE was
expressed as mg gallic acid equivalent (GAE)/g of creatinine.
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All details have been previously described byMedina-Remo´n
et al. [14].
2.3. Clinical Measurements. Weight and height were mea-
sured with light clothing and no shoes with a calibrated
balance and a wall-mounted calibrated stadiometer, respec-
tively. BMI was calculated as weight in kilograms divided
by the square of height in meters. For the measurement
of blood pressure (BP), a validated semiautomatic sphyg-
momanometer (Omron HEM-705CP) was used by trained
nurses. Measurements were taken at 5-minute intervals with
participants in a seated position. Data were collected as an
average of 2 measurements in each arm, repeated twice [31].
Plasma glucose, total cholesterol, and triglyceride con-
centrations were measured using standard enzymatic auto-
mated methods. Levels of HDL-cholesterol were measured
by an enzymatic procedure after precipitation, and LDL-
cholesterol was estimated by the Friedewald formula [32].
2.4. Statistical Analysis. Results were expressed as mean ±
SD for continuous variables or percentages for categorical
variables. Kolmogorov tests were applied to examine the
normality distribution and skewness. All participants were
divided into three categories according to changes in TPE
during the follow-up (ΔTP < −11.4mg gallic acid/g cre-
atinine, −11.4 ≤ ΔTP ≤ 24.6mg gallic acid/g creatinine,
and ΔTP > 24.6mg gallic acid/g creatinine). Changes in
nutrient and key food consumption during the follow-up
were assessed with ANOVA for repeated measurements
analysis. Bonferroni post hoc test and paired t-test were used
to compare each variable within and between groups.
Multivariate linear regression models were used to assess
the relationship between serum glucose, total cholesterol,
HDL, LDL, triglyceride concentrations, systolic blood pres-
sure (SBP), diastolic blood pressure (DBP), and heart rate,
and tertiles of changes in TPE during the follow-up period,
adjusted for potential confounders (sex, age, intervention
groups, BMI, smoking status, family history of CHD, physical
activity, hypertension, diabetes, dyslipidemia, medication
use, and 14-unit Mediterranean diet score at baseline). Sen-
sitivity analyses were used to further assess the relationship
between specific cardiovascular risk factors and subcate-
gories.
General LinearModel (GLM) approach to ANCOVAwas
used to determine differences between tertiles of changes
in TPE after 5-year follow-up, adjusted for potential con-
founders as did in multivariate linear regression models.
All analyses were performed using SPSS software V21.0
(Chicago, USA). All models were tested for the detection of
outliers, multicollinearity, homoscedasticity, and normality
and independence of errors. All statistical tests were two-
tailed, and the significance level was 𝑃 < 0.05.
3. Results
After 5 years of follow-up of 612 participants randomly
selected for this substudy of the PREDIMED trial, 39 were
excluded because of extreme TPE values, hence a total of
573 participants were included in the present study. Baseline
characteristics of participants grouped by tertiles of changes
in TPE during the follow-up are shown in Table 1. According
to the study design, the average age was 67.3 ± 5.9 years with
a BMI of 29.2 ± 3.3 kg/m2. Most of the participants gathered
a high number of cardiovascular risk factors: 41.5% had
diabetes; 80.5% had hypertension; 66.8% had dyslipidemia;
16.9% were current smokers, and 37.5% had a family history
of CHD. In the second tertile, individuals were less likely to
be women and had a higher body weight.
Table 2 shows changes in key food consumption during
the follow-up. Most key foods changed considerably after
the long-term intervention, with the exception of legumes
and chocolate. Table 3 summarizes information on nutrient
intake at baseline and 5 years according to changes in TPE
during the follow-up. Comparing nutrient intake at 5 years
versus baseline, we observed a significant increase in total fat,
fibre, monounsaturated fatty acids (MUFA), polyunsaturated
fatty acids (PUFA), K, and Mg, while other items such
as total carbohydrates, protein, saturated fatty acids (SFA),
Na, and cholesterol remained unchanged. This may be due
to dietary changes based on recommendations to adhere
to a Mediterranean diet, which is characterized by a high
consumption of vegetables, fruits, olive oil, wine, and nuts
and a low consumption of red meat, high-fat dairy products,
and sweets. However, there were no significant changes when
comparing tertiles and their interaction. In addition, we
found that significant changes in TPE did not significantly
affect the intake of nutritional elements among groups.
Several antioxidant substances such as sulfur dioxide,
ascorbic acid, sugar, aromatic amines, organic acid, Fe(II),
and nonphenolic organic substances might affect total
polyphenol when applying Folin-Ciocalteu assay; however,
after a solid phase extraction (SPE), the aforementioned
interfering substances were eliminated through the cleaning-
up process [14].
Linear regression analyses were conducted to assess the
relationship between TPE (Q
1
= −48.70 ± 30.11mg GAE/g
creatinine; Q
2
= 6.95 ± 10.55mg GAE/g creatinine; Q
3
=
64.48 ± 31.61mg GAE/g creatinine) and clinical possible
cardiovascular risk factors (plasma glucose, triglyceride,
cholesterol, HDL-c, and LDL-c concentrations, and SBP,DBP,
and heart rate). Results are shown in Table 4. Significant
inverse associations were found between tertiles of changes
in TPE and glucose (𝛽 = −4.372; 𝑃 = 0.026), triglycerides
(𝛽 = −8.572; 𝑃 = 0.006), and DBP (𝛽 = −1.156; 𝑃 =
0.031) after adjustment for potential confounders. However,
other parameters did not show significant associations. The
standardized coefficients (Beta) in the model were used to
measure degrees of contribution to different risk factors.
Results indicate that, among the CVD risk factors, triglyc-
eride levels showed the highest beneficial effects of dietary
polyphenol intake (Beta = −0.126; 𝑃 = 0.031).
We also conducted sensitivity analyses to ascertain
whether significant changes were related to specific variables.
As shown in Table 5, men were more likely to improve their
plasma triglyceride concentration than women, according to
tertiles of changes in TPE. In contrast, the lowering effects
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Table 1: Baseline characteristics of participants according to tertiles of changes in TPE.
TPE (mg GAE/g creatinine)
𝑄
1
𝑄
2
𝑄
3
𝑃
(ΔTP < −11.4) (−11.4 ≤ ΔTP ≤ 24.6) (ΔTP > 24.6)
Number of subjects 191 191 191
Women, 𝑛 (%) 101 (52.9) 83 (43.5) 112 (58.6) 0.011
Age (y), mean (SD) 66.7 (5.9) 67.3 (5.8) 68.00 (6.0) 0.113
Weight (kg), mean (SD) 73.9 (10.6) 77.1 (11.6) 74.5 (10.7) 0.01
BMI (kg/m2), mean (SD) 28.9 (3.1) 29.6 (3.5) 29.2 (3.2) 0.103
Systolic BP (mmHg), mean (SD) 149.8 (17.9) 151.6 (16.9) 152.8 (18.6) 0.238
Diastolic BP (mmHg), mean (SD) 84.3 (9.8) 85.9 (10.0) 85.5 (10.4) 0.269
Hypertension, 𝑛 (%) 151 (79.1) 152 (79.6) 158 (82.7) 0.621
Diabetes, 𝑛 (%) 78 (40.8) 85 (44.5) 75 (39.3) 0.567
Dyslipidemia, 𝑛 (%) 136 (72.3) 117 (61.3) 128 (67) 0.074
Smoking status 0.641
Current, 𝑛 (%) 35 (18.3) 34 (17.8) 28 (14.7) 0.586
Former, 𝑛 (%) 36 (18.8) 43 (22.5) 47 (24.6) 0.388
Never, 𝑛 (%) 120 (62.8) 114 (59.7) 116 (60.7) 0.814
Family history of CHD, 𝑛 (%) 65 (35.3) 75 (40.3) 75 (41.2) 0.460
Medication
Aspirin, 𝑛 (%) 33 (32.0) 35 (34.0) 35 (34.0) 0.949
Antihypertensive drugs, 𝑛 (%) 131 (68.6) 142 (74.3) 141 (73.8) 0.381
Hypolipidemic drugs, 𝑛 (%) 91 (47.6) 70 (36.6) 78 (40.8) 0.089
Insulin, 𝑛 (%) 10 (5.2) 9 (4.7) 8 (4.2) 0.890
Oral hypoglycemic drugs, 𝑛 (%) 40 (20.9) 46 (24.1) 45 (23.6) 0.736
Vitamin or minerals, 𝑛 (%) 18 (9.5) 16 (8.5) 13 (6.9) 0.644
Educational level
Primary school, 𝑛 (%) 140 (74.1) 139 (73.5) 146 (76.8)
0.793High school, 𝑛 (%) 32 (16.9) 28 (14.8) 28 (14.7)
University, 𝑛 (%) 17 (9.2) 22 (11.6) 16 (8.4)
Physical activity at leisure time (MET-min/d) 275 (212) 287 (204) 269 (183) 0.696
Polyphenol intake (mg/d) 853.4 (239.8) 831.2 (248.9) 882.7 (247.8) 0.135
BMI: body mass index; CHD: coronary heart disease; GAE: gallic acid equivalent; TPE: total polyphenol excretion.
Data are given as means (SD) for continuous variables and percentages for categorical variables; 𝑃 < 0.05 indicates statistical significance.
∗
𝑃 values calculated by analysis of variance or 𝜒2 tests.
of higher polyphenol consumption on DBP were greater in
women. In addition, when the P-14 was considered sepa-
rately, higher scoring groups showed significant differences
in plasma triglyceride concentration according to tertiles of
changes in TPE.
4. Discussion
In this 5-year study of an elderly population at high car-
diovascular risk living in a Mediterranean country, we
observed that higher polyphenol intake, measured by TPE,
was inversely associated with some cardiovascular risk fac-
tors. The observed benefits on CVDs were ascribable to a
reduction in plasma glucose and triglyceride concentrations
and a diminution of DBP. This may partly explain the
decreasedCVDrisk shownby people following a polyphenol-
rich diet such as the Mediterranean diet.
The beneficial effects of polyphenols consumption on
major cardiovascular events in the PREDIMED cohort have
been published before [20]. The difference between our
findings and other reported results lies in the measurement
of polyphenols in urine as biomarker of polyphenol intake.
Given that more than 8000 phenolic structures exist in
nature, beneficial effects from polyphenols depend on a vari-
ety of factors, including total intake, food cooking processes,
digestion, absorption, metabolic pathways in vivo, or even
differences between individuals [33]. Therefore, TPE, as a
biomarker of total polyphenol intake, may provide a more
accurate insight into the effects of polyphenols on CVDs than
other dietary assessment methods.
Previous clinical studies on the benefits of polyphenols
on the cardiovascular system have provided inconsistent
results. A 12-week follow-up clinical trial conducted in Korea
reported a strong inverse association between consump-
tion of polyphenol extracts from Ecklonia cava and serum
glucose, SBP, and HDL concentration [17]. In contrast, a
recent randomized control trial performed with 67 elderly
men at high cardiovascular risk found an increase in HDL
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Table 2: Changes in daily intake of key foods after 5 years with energy adjustment categorized by tertile of changes in TPEa.
TPE (mg GAE/g creatinine)
𝑄
1
𝑄
2
𝑄
3
𝑃
b
(ΔTP < −11.4 ) (−11.4 ≤ ΔTP ≤ 24.6) (ΔTP > 24.6)
Mean SD Mean SD Mean SD Timec Groupd Time ∗ Groupe
Vegetables (g/d) Baseline 302.1 117.5 293.9 109.0 289.6 118.4 <0.001 0.195 0.369
5 years 366.0∗∗ 122.9 340.7∗∗ 115.8 354.3∗∗ 120.9
Fruits (g/d) Baseline 346.3 176.7 354.7 169.3 385.4 183.6 <0.001 0.477 0.103
5 years 459.4∗∗ 181.4 456.4∗∗ 172.6 454.0∗∗ 158.8
Legumes (g/d) Baseline 18.7 7.2 19.2 7.2 19.69 8.8 0.445 0.149 0.736
5 years 18.7 8.3 19.1 7.7 19.9 8.1
Cereals (g/d) Baseline 240.0 73.2 242.9 79.2 238.9 70.7 <0.001 0.867 0.712
5 years 221.1∗∗ 63.4 216.4∗∗ 68.5 216.1∗∗ 63.0
Milk (g/d) Baseline 368.8 201.3 345.4 193.9 393.2 233.2 0.005 0.300 0.166
5 years 402.2∗ 223.4 386.4∗∗ 204.3 395.6 196.6
Meat (g/d) Baseline 140.9 49.1 140.1 48.8 138.0 45.3 <0.001 0.992 0.431
5 years 126.6∗∗ 41.9 126.9∗∗ 43.3 130.1 44.1
Fish (g/d) Baseline 94.7 37.2 90.4 39.1 91.7 39.2 <0.001 0.521 0.882
5 years 101.4 45.6 98.8∗∗ 43.2 97.8∗ 36.2
Pastries (g/d) Baseline 26.1 26.1 25.7 27.1 26.6 25.1 0.001 0.846 0.485
5 years 20.1 24.2 23.1 28.4 21.5 27.3
EVOO (g/d) Baseline 24.1 24.2 21.8 23.8 21.3 22.9 <0.001 0.848 0.346
5 years 48.2∗∗ 22.8 48.1∗∗ 25.0 49.7∗∗ 23.1
Nuts (g/d) Baseline 11.0 12.1 9.8 13.1 10.6 13.1 <0.001 0.794 0.656
5 years 16.0∗∗ 12.5 16.1∗∗ 13.1 16.7∗∗ 12.2
Wine (g/d) Baseline 98.3 140.1 105.2 157.2 96.8 136.1 0.002 0.781 0.979
5 years 80.1∗∗ 130.5 89.0 130.8 80.7 123.4
Folic acid (𝜇g/d) Baseline 376.7 83.8 379.4 81.1 381.9 87.6 <0.001 0.939 0.322
5 years 432.6∗∗ 75.9 425.3∗∗ 87.3 424.5∗∗ 72.4
Coffee (mL/d) Baseline 38.4 57.0 33.2 44.2 33.9 47.2 0.004 0.902 0.258
5 years 27.4∗ 48.0 28.6 46.4 30.7 48.8
Chocolate (g/d) Baseline 2.9 5.7 2.5 4.7 3.1 5.9 0.940 0.422 0.203
5 years 2.2 4.2 3.1∗ 6.1 3.4 7.9
aData are given as means (SD); 𝑃 < 0.05 indicates statistical significance. EVOO: extra virgin olive oil; GAE: gallic acid equivalent; TPE: total polyphenol
excretion. Values with asterisks are statistically different from baseline values by the paired-samples 𝑡-test (∗𝑃 < 0.05; ∗∗𝑃 < 0.01).
bData analysed by repeated-measures 2-factor ANOVA.
cComparison between the time before and after intervention.
dComparison between tertiles of TPE changes.
eComparison between measurements obtained before and after intervention and between tertiles of TPE changes.
after consumption of red wine, whereas fasting glucose was
kept constant throughout the study, which differs from our
observation [34]. Another contrasting result was found in
participants with type-2 diabetes, who improved their HDL
level and decreased total cholesterol after the consumption
of polyphenol-rich chocolate [35]. In addition, a group of
overweight participants consuming polyphenol-rich dark
chocolate had lower plasma glucose, SBP, and DBP after
the intervention, which partly agrees with our findings [18].
However, in the present study, we found no association
between polyphenol intake and cholesterol profiles or SBP.
Participants who increased their polyphenol intake
showed a reduction in plasma glucose concentrations, adding
to the evidence that polyphenol-rich diets protect the car-
diovascular system by improvements in glycemic control. A
similar clinical trial performed on 78 participants at high
cardiovascular risk, administration of polyphenol-rich foods,
improved glucose metabolism by increasing early insulin
secretion and insulin sensitivity [36]. Another cross-sectional
study in an elderly population reported that green tea
consumption was inversely associated with fasting blood glu-
cose concentrations, though without adjusting for potential
6 Oxidative Medicine and Cellular Longevity
Table 3: Changes in nutrient intake after 5 years with energy adjustment categorized by tertile of changes in TPEa.
TPE (mg GAE/g creatinine)
𝑄
1
𝑄
2
𝑄
3
𝑃
b
(ΔTP < −11.4) (−11.4 ≤ ΔTP ≤ 24.6) (ΔTP > 24.6)
Mean SD Mean SD Mean SD Timec Groupd Time ∗ Groupe
Total carbohydrates (g/d) Baseline 235.6 36.5 238.4 43.2 239.9 35.9 0.736 0.964 0.41
5 years 239.7 63.1 235.0 68.9 235.6 61.0
Protein (g/d) Baseline 88.4 36.5 91.2 43.2 92.7 35.9 0.12 0.649 0.498
5 years 94.5 18.6 92.7 19.5 94.4 17.7
Total fat (g/d) Baseline 102.5 12.8 100.8 12.6 102.7 13.6 <0.001 0.528 0.331
5 years 110.7∗∗ 23.1 112.9∗∗ 25.6 113.4∗∗ 24.4
MUFA (g/d) Baseline 53.5 13.6 52.3 17.4 51.6 15.2 <0.001 0.97 0.19
5 years 58.3∗∗ 12.7 59.6∗∗ 13.5 59.8∗∗ 13.5
SFA (g/d) Baseline 25.5 9.0 24.6 10.1 24.0 9.7 0.949 0.887 0.114
5 years 24.2 6.4 24.8 7.4 25.1 7.3
PUFA (g/d) Baseline 15.7 4.7 15.7 6.1 15.6 5.4 <0.001 0.716 0.675
5 years 19.0∗∗ 5.9 19.0∗∗ 5.6 19.6∗∗ 5.5
Alcohol (g/d) Baseline 14.1 5.2 13.3 5.4 13.4 4.8 0.039 0.979 0.75
5 years 11.9 14.6 12.4 15.2 12.2 14.7
Fibre (g/d) Baseline 24.2 6.0 24.6 5.6 25.2 6.4 <0.001 0.564 0.204
5 years 26.6∗∗ 7.5 25.8 7.4 26.4 7.0
Cholesterol (mg/d) Baseline 352.4 84.6 353.1 94.6 350.5 94.0 0.2 0.946 0.975
5 years 359.9 90.9 358.0 98.7 356.8 92.7
Na (mg/d) Baseline 2322.4 479.6 2273.1 528.7 2263.7 479.9 0.736 0.963 0.41
5 years 2229.8 644.5 2230.8 728.0 2253.7 652.0
K (mg/d) Baseline 4230.9 723.7 4164.3 682.7 4300.6 796.1 <0.001 0.234 0.542
5 years 4654.5∗∗ 826.8 4546.0∗∗ 963.7 4614.7∗∗ 805.9
Mg (mg/d) Baseline 359.5 62.7 358.4 58.1 367.1 61.8 <0.001 0.432 0.365
5 years 398.5∗∗ 82.1 388.1∗∗ 86.4 394.3∗∗ 80.8
SFA: saturated fatty acids,MUFA:monounsaturated fatty acids, PUFA: polyunsaturated fatty acids, GAE: gallic acid equivalent; TPE: total polyphenol excretion.
aData are given as means (SD); 𝑃 < 0.05 indicates statistical significance. Values with asterisks are statistically different from baseline by paired-samples 𝑡-test
(∗𝑃 < 0.05; ∗∗𝑃 < 0.01).
bData analysed by repeated measures 2-factor ANOVA.
cComparison between the time before and after intervention.
dComparison between tertile changes in TPE.
eComparison between measures obtained before and after intervention and between tertiles of TPE changes.
confounders [37]. Despite the abundance of results from
different clinical trials, animal models, and in vitro tests,
the mechanisms for hypoglycemic effects of polyphenols
still warrant discussion. Potential explanations for these
putative protective effects include reduced absorption of
total carbohydrate in the intestine, modulation of enzymes
related to glucose metabolism, stimulation of insulin secre-
tion, improvement of 𝛽-cell function and insulin action,
reduction in oxidative stress, inhibition of glucose transport,
and enhanced vascular function [36, 38–40].
Triglycerides are considered the highest source of energy,
and inhibition of triglyceride absorption also plays a role in
the prevention of CVDs [41]. In the present study, increasing
polyphenol intake was inversely associated with triglyceride
levels, in agreement with some previous studies. Sugiyama
et al. investigated the inhibitory effect of oligomeric pro-
cyanidins from apples on triglyceride absorption, explained
by the inhibition of pancreatic lipase activity in vivo and
in animal models [42]. Data from animal models indi-
cated that such lowering effects could be attributed to the
very low-density lipoprotein (VLDL) secretion rates and a
decrease in apolipoprotein B secretion [43]. In addition, a
study of haemodialysis patients fed with polyphenol-rich
pomegranate juice also reported improvements in triglyc-
eride levels, but this was explained by an inhibition of
intestinal absorption and clearance of plasma triglycerides
in vivo[19]. The variety of plausible mechanisms put forward
to explain these effects, such as absorption, metabolism, and
elimination during metabolic processes, reflect the highly
varied chemical structure of polyphenols. Unlike the cur-
rent study, most clinical trials have focused on a single
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Table 4: Multivariate linear regression analyses with changes in cardiovascular risk factors as dependent variables and tertiles of changes in
TPE in spot urine samples (mg GAE/g creatinine) as exposure variables, adjusted for potential confounders.
𝛽 SE Beta Sig. 95% CI
Change in GLU (mg/dL)
Model 1 −4.164 1.979 −0.095 0.036 −8.053 −0.275
Model 2 −4.316 1.981 −0.098 0.030 −8.208 −0.424
Model 3 −4.355 1.949 −0.099 0.026 −8.186 −0.525
Model 4 −4.372 1.953 −0.099 0.026 −8.209 −0.534
Change in COL (mg/dL)
Model 1 −2.51 2.001 −0.057 0.210 −6.442 1.421
Model 2 −2.236 2.011 −0.050 0.267 −6.187 1.715
Model 3 −1.845 2.013 −0.042 0.360 −5.800 2.109
Model 4 −1.802 2.015 −0.041 0.372 −5.762 2.157
Change in HDL (mg/dL)
Model 1 0.102 0.448 0.010 0.820 −0.778 0.982
Model 2 0.135 0.448 0.014 0.763 −0.744 1.015
Model 3 0.133 0.456 0.014 0.771 −0.764 1.030
Model 4 0.174 0.454 0.018 0.701 −0.718 1.067
Change in LDL (mg/dL)
Model 1 −0.205 1.775 −0.005 0.908 −3.693 3.283
Model 2 −0.039 1.784 −0.001 0.983 −3.545 3.467
Model 3 0.448 1.783 0.012 0.802 −3.056 3.952
Model 4 0.469 1.786 0.012 0.793 −3.041 3.979
Change in TG (mg/dL)
Model 1 −8.356 3.06 −0.123 0.007 −14.369 −2.344
Model 2 −8.563 3.058 −0.126 0.005 −14.572 −2.554
Model 3 −8.627 3.094 −0.127 0.006 −14.708 −2.546
Model 4 −8.572 3.099 −0.126 0.006 −14.662 −2.483
Change in SBP (mmHg)
Model 1 −1.367 0.994 −0.058 0.169 −3.319 0.585
Model 2 −1.222 1.001 −0.052 0.222 −3.188 0.744
Model 3 −1.127 1.003 −0.048 0.262 −3.098 0.843
Model 4 −1.098 1.005 −0.046 0.275 −3.071 0.876
Change in DBP (mmHg)
Model 1 −1.316 0.531 −0.104 0.013 −2.359 −0.273
Model 2 −1.254 0.532 −0.099 0.019 −2.298 −0.209
Model 3 −1.153 0.532 −0.091 0.031 −2.198 −0.108
Model 4 −1.156 0.533 −0.091 0.031 −2.203 −0.109
Change in HR
Model 1 −0.002 0.555 0.000 0.997 −1.091 1.087
Model 2 0.043 0.559 0.003 0.938 −1.055 1.142
Model 3 −0.011 0.567 −0.001 0.985 −1.125 1.103
Model 4 −0.074 0.565 −0.006 0.895 −1.184 1.035
GLU: glucose, COL: total cholesterol, HDL: high-density lipoprotein, LDL: Low-density lipoprotein, TG: triglycerides, SBP: systolic blood pressure, DBP:
diastolic blood pressure, and HR: heart rate.
𝛽: nonstandardized coefficient (regression line coefficient); SE: standard error; Beta: standardized coefficient; CI: confidence interval; 𝑃: two-sided test of
significance.
Model 1: unadjusted; Model 2 adjusted for sex, age, and intervention groups; Model 3 adjusted as in Model 2 plus BMI, smoking status, family history of
CHD, physical activity, hypertension, diabetes, dyslipidemia, and medication use: antihypertensive drugs, vitamins, insulin, oral hypoglycemic drugs, aspirin,
or other antiplatelet drug; Model 4 was adjusted as in Model 3 plus 14-unit Mediterranean diet score.
polyphenol-rich food such as dark chocolate, wine, or green
tea. Therefore, considering that the Mediterranean diet is a
constellation of several polyphenol-rich foods, it is difficult
to draw a single mechanism to explain the lowering effects
found on triglycerides.
Hypertension is a well-established risk factor for CVDs
[44]. There is evidence from our study and others that
increasing polyphenol intake is associated with lower BP.
Both DASH (Dietary Approaches to Stop Hypertension)
and SUN (Seguimiento Universidad de Navarra) studies
emphasize that the consumption of plant-derived foods,
particularly fruits, vegetables, nuts, and olive oil, is inversely
associated with BP [45–47]. We previously reported that
greater TPE was inversely associated with BP [13]. However,
we found significant associations only for DBP, and not SBP.
Another PREDIMED clinical substudy based on a 4-year
intervention also supports our findings [48]. Mechanisms
of the BP lowering effect could involve endothelial nitric
oxide (NO) production. NO plays a fundamental role in the
regulation of the vascular system, and vascular homeostasis
is achieved only when NO levels are adequate [6]. Briefly,
polyphenols induce NO production by promoting endothe-
lial nitric oxide synthase (eNOS) expression, generating
vascular relaxing factors such as prostacyclin (PGI2) and
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inhibiting synthesis of the vasoconstrictor endothelin-1 (ET-
1) in vascular endothelial cells [49]. Strong and positive
association between polyphenol intake and plasma NO levels
has been previously demonstrated by our group [8].
Some study limitations deserve to be noted. First, given
that this substudy was conducted only among elderly subjects
at high cardiovascular risk, it is difficult to extrapolate the
results to the general population. Second, even though we
adjusted potential confounders relative to CVD risk, residual
confounding could still exist. Nonetheless, our study adds
new evidence in support of a preventative effect of a long-
term polyphenol intake on CVDs.
Compared with previous studies, the present study also
has several strengths. Firstly, even though biomarkers are
necessary to assess the compliance of the intervention,
it is difficult to find a reliable and available biomarker.
TPE in urine could be useful as a marker of compliance
in intervention studies with foods with high-polyphenol
content such as fruits, vegetables, wine, chocolate, tea, and
coffee, while other markers are not suitable; moreover, in
comparison with measuring the total polyphenol intake
through self-reported information based on FFQ, the use of
TPE, a biomarker of polyphenol intake, could provide more
precise evidence [20, 50]. Secondly, the long duration of the
intervention should also be considered as strength, since only
few studies have tested associations between polyphenols and
cardiovascular risk factors in such long-term intervention
[8, 51, 52]. Thirdly, the selection of participants is a group
of free-living individuals reproducing real-life conditions
with home-prepared, energy-unrestricted foods. Fourthly,
the Folin-Ciocalteu assay is a rapid, cheaper, and envi-
ronmentally friendly measurement without requirement of
dedicated instrumentation, which could be suggested to be
applied in large intervention studies in the future.
In conclusion, in this 5-year study within the frame of
the PREDIMED trial conducted in subjects at high cardio-
vascular risk, we found that polyphenol intake measured by
TPE was inversely associated with some clinical cardiovas-
cular risk factors, namely, plasma glucose and triglycerides
concentrations and SBP, suggesting that intake of polyphenols
provides protection against CVDs throughout these mech-
anisms. Further research is needed to confirm the current
findings in the general population.
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